@article{MuozMartnez_S-2022_86397,
title = {Outcome of liver cancer patients with SARS‐CoV‐2 infection},
author = {Muñoz‐Martínez, S. and Sapena, V. and Forner, A. and Bruix, J. and Sanduzzi‐Zamparelli, M. and Ríos, J. and Bouattour, M. and El Kassas, M. and Leal, C. and Mocan, T. and Nault, J. and Alves, R. and Reeves, H. and Fonseca, L. and García‐Juárez, I. and Pinato, D. and Varela, M. and Alqahtani, S. and Alvares‐da‐Silva, M. and Bandi, J. and Rimassa, L. and Lozano, M. and González Santiago, J. and Tacke, F. and Sala, M. and Anders, M. and Lachenmayer, A. and Piñero, F. and França, A. and Guarino, M. and Elvevi, A. and Cabibbo, G. and Peck‐Radosavljevic, M. and Rojas, Á. and Vergara, M. and Braconi, C. and Pascual, S. and Perelló, C. and Mello, V. and Rodríguez‐Lope, C. and Acevedo, J. and Villani, R. and Hollande, C. and Vilgrain, V. and Tawheed, A. and Ferguson Theodoro, C. and Sparchez, Z. and Blaise, L. and Viera‐Alves, D. and Watson, R. and Carrilho, F. and Moctezuma‐Velázquez, C. and D'Alessio, A. and Iavarone, M. and Reig, M.},
month = {may},
year = {2022},
abstract = {Background &amp; Aims: Information about the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with liver cancer is lacking. This study characterizes the outcomes and mortality risk in this population.},
journal = {Liver International},
publisher = {Wiley},
url = {https://publichealthscotland.scot/id/86397},
}
